Fifth Lane Capital »

SPDR S&P Biotech shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $296k 3.0k 98.80
2022-06-30 $243k 3.1k 78.13

More positions owned by Fifth Lane Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Investcorp Europe Acquisitio Class A Ord Shs (IVCB)
Southwestern Energy Company
Endeavor Group Hldgs Cl A Com (EDR)
Albertsons Cos Common Stock (ACI)
Envestnet (ENV)
SITE Centers Corp
Smartsheet Com Cl A (SMAR)
Monolithic Power Systems (MPWR)
Sbny 5.0 31 Dec 2049 A - P Common Shares (SBNYL)
Select Sector Spdr Tr Indl (XLI)
Ansys (ANSS)
Applovin Corp Com Cl A (APP)
Loar Holdings Com Shs (LOAR)
Ultragenyx Pharmaceutical (RARE)

View all positions for Fifth Lane Capital

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Bank of America Corporation
Citigroup
Jane Street
Citadel Advisors
Morgan Stanley
Susquehanna International
NWI Management
Bnp Paribas Arbitrage, Snc
Twin Tree Management
Parallax Volatility Advisers
Wells Fargo & Company
Logos Global Management

View all funds holding SPDR S&P Biotech